help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baumel, M. J.
Right arrow Articles by Pack, A. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baumel, M. J.
Right arrow Articles by Pack, A. I.

Am. J. Respir. Crit. Care Med., Vol 155, No. 1, 01 1997, 9-14.

Population and occupational screening for obstructive sleep apnea: are we there yet?

MJ Baumel, G Maislin and AI Pack
Department of Medicine, Center for Sleep and Respiratory Neurobiology, University of Pennsylvania Medical Center, Philadelphia 19104-4283, USA.

Several features of obstructive sleep apnea (OSA) suggest that it may be an appropriate disease for screening programs for general populations and more specific high-risk groups. Preliminary data suggest that OSA represents an important health problem in terms of high prevalence, increased levels of morbidity and mortality, and increased public safety risk. Furthermore, the chronicity of the disease and the relatively low levels of recognition of the disorder in the medical community suggest a potential for lead-time gains for screening programs. Specific groups that might be considered for screening programs include commercial vehicle operators, hazardous duty personnel, and certain groups of medical patients. The purpose of this clinical commentary is to consider the issues of population and specific group screening for OSA by reviewing the general principles of screening for chronic disease and then applying these principles specifically in the case of OSA. More extensive outcomes data relating levels of severity of the disorder to its potential adverse outcomes are needed and will assist in tailoring appropriate screening programs and determining the cost-effectiveness of screening various populations.


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
T. Young, P. E. Peppard, and D. J. Gottlieb
Epidemiology of Obstructive Sleep Apnea: A Population Health Perspective
Am. J. Respir. Crit. Care Med., May 1, 2002; 165(9): 1217 - 1239.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
T.A. McFadyen, C.A. Espie, N. McArdle, N.J. Douglas, and H.M. Engleman
Controlled, prospective trial of psychosocial function before and after continuous positive airway pressure therapy
Eur. Respir. J., December 1, 2001; 18(6): 996 - 1002.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
I. GURUBHAGAVATULA, G. MAISLIN, and A. I. PACK
An Algorithm to Stratify Sleep Apnea Risk in a Sleep Disorders Clinic Population
Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1904 - 1909.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. I. Loube and T. F. Andrada
Comparison of Respiratory Polysomnographic Parameters in Matched Cohorts of Upper Airway Resistance and Obstructive Sleep Apnea Syndrome Patients
Chest, June 1, 1999; 115(6): 1519 - 1524.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1997 American Thoracic Society